Dna Group (T.R.) Statistics

Total Valuation

Dna Group (T.R.) has a market cap or net worth of ILS 92.13 million. The enterprise value is 24.79 million.

Market Cap	92.13M
Enterprise Value	24.79M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Dna Group (T.R.) has 123.16 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	n/a
Shares Outstanding	123.16M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	52.38%
Owned by Institutions (%)	0.14%
Float	58.65M

Valuation Ratios

The trailing PE ratio is 6.18.

PE Ratio	6.18
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.94
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.65
EV / Sales	81.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 101.37

Current Ratio	101.37
Quick Ratio	101.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.62% and return on invested capital (ROIC) is -1.37%.

Return on Equity (ROE)	16.62%
Return on Assets (ROA)	-1.35%
Return on Capital (ROIC)	-1.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.77% in the last 52 weeks. The beta is 0.10, so Dna Group (T.R.)'s price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	+27.77%
50-Day Moving Average	82.35
200-Day Moving Average	76.70
Relative Strength Index (RSI)	35.60
Average Volume (20 Days)	65,187

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dna Group (T.R.) had revenue of ILS 306,000 and earned 15.05 million in profits. Earnings per share was 0.12.

Revenue	306,000
Gross Profit	306,000
Operating Income	-1.98M
Pretax Income	15.25M
Net Income	15.05M
EBITDA	n/a
EBIT	-1.98M
Earnings Per Share (EPS)	0.12

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	67.33M
Total Debt	n/a
Net Cash	67.33M
Net Cash Per Share	0.55
Equity (Book Value)	98.30M
Book Value Per Share	0.80
Working Capital	66.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	284,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -647.71% and 4,918.63%.

Gross Margin	100.00%
Operating Margin	-647.71%
Pretax Margin	4,982.68%
Profit Margin	4,918.63%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Dna Group (T.R.) does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on November 10, 2019. It was a reverse split with a ratio of 0.1666666667.

Last Split Date	Nov 10, 2019
Split Type	Reverse
Split Ratio	0.1666666667

Scores

Dna Group (T.R.) has an Altman Z-Score of 42.67.

Altman Z-Score	42.67
Piotroski F-Score	n/a